A women's reproductive health company
focused on mother and embryo safety

Cath Med CM

  • Cath Med was founded in April 2012 and it operates within the NGT Technology Incubator.
  • A functional prototype has been developed and has been tested to demonstrate proof-of-concept.
  • First production runs have been ordered and tested; product will be used for pre-clinical validations and clinical trials.
  • The Company will be conducting clinical trials throughout 2014 and anticipates achieving CE marking by the end of the year.

 

 

 

Go to top